h1

h2

h3

h4

h5
h6
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png

BIOLUMA: A Phase II Trial of Nivolumab and Ipilimumab in Lung Cancer - Prospective Evaluation of TMB in SCLC Patients = OA15.05 BIOLUMA: A Phase II Trial of Nivolumab and Ipilimumab in Lung Cancer - Prospective Evaluation of TMB in SCLC Patients

; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

In
IASLC 2019 World Conference on Lung Cancer : Conquering Thoracic Cancers Worldwide :7-10 September 2019, Barcelona, Spain

In
Journal of thoracic oncology : JTO 14(10, Supplement), Seiten/Artikel-Nr.:OA15.05

Konferenz/Event:IASLC 2019 World Conference on Lung Cancer , Barcelona , Spain , WCLC , 2019-09-07 - 2019-09-10

ImpressumAmsterdam : Elsevier

UmfangS247-S247

ISSN1556-0864

Online
DOI: 10.1016/j.jtho.2019.08.492


Einrichtungen

  1. Klinik für Onkologie, Hämatologie und Stammzelltransplantation (Med. Klinik IV) (9340106)


Thematische Einordnung (Klassifikation)
DDC: 610


Dokumenttyp
Abstract/Journal Article/Contribution to a conference proceedings

Format
online, print

Sprache
English

Anmerkung
No peer reviewed article

Externe Identnummern
WOS Core Collection: WOS:000492162201177

Interne Identnummern
RWTH-2019-10445
Datensatz-ID: 771830

Beteiligte Länder
Germany

 GO

Medline ; Allianz-Lizenz ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; IF >= 10 ; JCR ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
QR Code for this record

The record appears in these collections:
Document types > Events > Contributions to a conference proceedings
Document types > Articles > Journal Articles
Document types > Presentations > Abstracts
9340106_20140620
Public records
University Hospital
Publications database
 Record created 2019-11-11, last modified 2024-08-20
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)